ES2115622T3 - Clones moleculares de hiv-1 y usos de los mismos. - Google Patents

Clones moleculares de hiv-1 y usos de los mismos.

Info

Publication number
ES2115622T3
ES2115622T3 ES91920794T ES91920794T ES2115622T3 ES 2115622 T3 ES2115622 T3 ES 2115622T3 ES 91920794 T ES91920794 T ES 91920794T ES 91920794 T ES91920794 T ES 91920794T ES 2115622 T3 ES2115622 T3 ES 2115622T3
Authority
ES
Spain
Prior art keywords
hiv
present
envelope
invention refers
dna segments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920794T
Other languages
English (en)
Other versions
ES2115622T5 (es
Inventor
Marvin S Reitz Jr
Genoveffa Franchini
Phillip D Markham
Robert C Gallo
Franco C Lori
Mikulas Popovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24399839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2115622(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2115622T3 publication Critical patent/ES2115622T3/es
Publication of ES2115622T5 publication Critical patent/ES2115622T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Abstract

LA PRESENTE INVENCION SE REFIERE A LAS CEPAS MN-ST1 Y BA-L DEL HIV-1 LAS CUALES SON ISOTOPOS HIV-1 TIPICOS DE ESTADOS UNIDOS. LA PRESENTE INVENCION SE REFIERE A SEGMENTOS DNA QUE CODIFICAN LA PROTEINA DE LA ENVOLTURA DEL MN-ST1 O BA-L, PARA CONSTRUIR DNA QUE CONTIENE SEMEJANTES SEGMENTOS DNA Y PARA CELULAS HUESPED TRANSFORMADAS CON TALES COMPUESTOS. LOS AISLANTES VIRALES Y LAS PROTEINAS DE LA ENVOLVENTE DE LA PRESENTE INVENCION, SON DE VALOR PARA USO EN VACUNAS Y ENSAYOS BIOLOGICOS PARA LA DETECCION DE INFECCION HIV-1 EN MUESTRAS BIOLOGICAS, TALES COMO MUESTRAS DE BANCOS DE SANGRE.
ES91920794T 1990-10-17 1991-10-17 Clones moleculares de hiv-1 y usos de los mismos. Expired - Lifetime ES2115622T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59949190A 1990-10-17 1990-10-17

Publications (2)

Publication Number Publication Date
ES2115622T3 true ES2115622T3 (es) 1998-07-01
ES2115622T5 ES2115622T5 (es) 2003-03-16

Family

ID=24399839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920794T Expired - Lifetime ES2115622T5 (es) 1990-10-17 1991-10-17 Clones moleculares de hiv-1 y usos de los mismos.

Country Status (10)

Country Link
US (3) US5420030A (es)
EP (1) EP0554389B2 (es)
JP (1) JP2767078B2 (es)
AT (1) ATE163676T1 (es)
AU (1) AU649502B2 (es)
CA (1) CA2093427C (es)
DE (1) DE69129034T3 (es)
DK (1) DK0554389T4 (es)
ES (1) ES2115622T5 (es)
WO (1) WO1992006990A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE4228787A1 (de) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate
CA2107732C (en) * 1992-10-06 2003-04-08 Lutz G. Gurtler Retrovirus from the hiv group and its use
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
EP0638316B1 (en) * 1993-08-11 2003-05-28 Wyeth Recombinant adenovirus vaccines
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6585979B1 (en) * 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
FR2756843B1 (fr) * 1996-12-09 1999-01-22 Inst Nat Sante Rech Med Souches de vih-1 non-m non-o, fragments et applications
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
US6322976B1 (en) * 1998-05-28 2001-11-27 Medical Research Council Compositions and methods of disease diagnosis and therapy
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6582920B2 (en) * 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
ATE414794T1 (de) 2000-09-01 2008-12-15 Gen Probe Inc Amplifizierung von hiv-1 sequenzen zur detektion von sequenzen, die mit wirkstoff-resistenz mutationen einhergehen
JP2006504435A (ja) * 2002-05-10 2006-02-09 ザ ヘンリー エム． ジャクソン ファウンデイション ＨＩＶ−１のｇｐ１２０のｇｐ４１への相互作用部位
WO2004050856A2 (en) * 2002-12-03 2004-06-17 University Of Massachusetts Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
JP4038679B2 (ja) * 2003-05-13 2008-01-30 住友電気工業株式会社 半導体レーザーバーの固定用治具
US20080181906A1 (en) * 2003-05-19 2008-07-31 Haynes Barton F Polyvalent Immunogen
EP2121984A2 (en) * 2007-03-16 2009-11-25 454 Life Sciences Corporation System and method for detection of hiv drug resistant variants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
ES2166748T3 (es) * 1989-05-25 2002-05-01 Novartis Ag Represor multivalente de la funcion genica.
EP0532673A1 (en) * 1990-06-08 1993-03-24 Repligen Corporation Immunoassays for anti-hiv-1 antibodies

Also Published As

Publication number Publication date
ATE163676T1 (de) 1998-03-15
AU8936391A (en) 1992-05-20
US5576000A (en) 1996-11-19
DE69129034T2 (de) 1998-10-08
EP0554389B1 (en) 1998-03-04
US5420030A (en) 1995-05-30
ES2115622T5 (es) 2003-03-16
DK0554389T3 (da) 1998-12-07
CA2093427A1 (en) 1992-04-18
CA2093427C (en) 2008-01-15
US5869313A (en) 1999-02-09
EP0554389A4 (en) 1994-07-06
JP2767078B2 (ja) 1998-06-18
WO1992006990A1 (en) 1992-04-30
EP0554389A1 (en) 1993-08-11
DE69129034T3 (de) 2003-05-08
DK0554389T4 (da) 2002-11-11
JPH05507205A (ja) 1993-10-21
DE69129034D1 (de) 1998-04-09
EP0554389B2 (en) 2002-08-14
AU649502B2 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
ES2100174T3 (es) Nuevos anticuerpos reactivos con carcinomas humanos.
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
SE9102974D0 (sv) Adenovira och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES2126620T3 (es) Retrovirus del grupo de los vih y su utilizacion.
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
MX9202875A (es) Una molecula de dna recombinante y procedimiento para su obtencion.
MX9205985A (es) Epitopes de las celulas t de los alergenos principales del genero dermatophagoides y composiciones farmaceuticas que los contienen.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
DK164088D0 (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
YU152587A (sh) Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ES2194024T3 (es) Una proteina de de superficie celular, denominada proteina rib, que confiere inmunidad a muchas cepas de estreptococos del grupo b; procedimiento para purificar la proteina, kit de reactivos y composicion farmaceutica.
ES2044881T3 (es) Procedimiento para la preparacion de una fosfoproteina estructural (pp 150) del citomegalovirus humano.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
MX9301675A (es) Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno.
ES2044976T3 (es) Preparados activos frente a infecciones por pseudomonas aeruginosa y procedimiento para su fabricacion.
ES2080023B1 (es) Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
DK0491713T3 (da) Rubella El-peptider og C-peptider
ES2160594T3 (es) Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 554389

Country of ref document: ES